Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,837,502
+$865,848 QoQ
Shares Held
103,131
+10.1% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 252 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. CLDX ranks #90 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,837,502 | 103,131 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,971,654 | 93,684 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,448,309 | 90,144 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,040,778 | 78,886 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,279,727 | 62,886 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $951,839 | 52,443 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,063,891 | 42,101 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,401,406 | 41,230 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,522,331 | 41,133 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,996,184 | 214,348 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,214,947 | 257,563 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,021,954 | 37,135 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $980,915 | 28,910 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,423,711 | 95,156 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,408,801 | 76,482 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $477,221 | 16,977 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $538,498 | 19,974 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $617,268 | 18,123 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,024,445 | 207,672 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,829,849 | 533,985 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,392,809 | 430,407 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $5,366,197 | 260,495 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $7,927,880 | 534,584 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||